These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22640698)

  • 1. A case of EBV driven haemophagocytic lymphohistiocytosis complicating a teenage Crohn's disease patient on azathioprine, successfully treated with rituximab.
    Fitzgerald MP; Armstrong L; Hague R; Russell RK
    J Crohns Colitis; 2013 May; 7(4):314-7. PubMed ID: 22640698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crohn's disease complicated by Epstein-Barr virus-driven haemophagocytic lymphohistiocytosis successfully treated with rituximab.
    Thompson G; Pepperell D; Lawrence I; McGettigan BD
    BMJ Case Rep; 2017 Feb; 2017():. PubMed ID: 28228435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-associated lymphoproliferation awareness in hemophagocytic syndrome complicating thiopurine treatment for Crohn's disease.
    Serrate C; Silva-Moreno M; Dartigues P; Poujol-Robert A; Sokol H; Gorin NC; Coppo P
    Inflamm Bowel Dis; 2009 Oct; 15(10):1449-51. PubMed ID: 19177429
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.
    Chellapandian D; Das R; Zelley K; Wiener SJ; Zhao H; Teachey DT; Nichols KE;
    Br J Haematol; 2013 Aug; 162(3):376-82. PubMed ID: 23692048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal Epstein-Barr virus primo infection in a 25-year-old man treated with azathioprine for Crohn's disease.
    N'guyen Y; Andreoletti L; Patey M; Lecoq-Lafon C; Cornillet P; Léon A; Jaussaud R; Fieschi C; Strady C
    J Clin Microbiol; 2009 Apr; 47(4):1252-4. PubMed ID: 19193838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemophagocytic syndrome in an adolescent with Crohn disease receiving azathioprine and infliximab.
    Francolla KA; Altman A; Sylvester FA
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):193-5. PubMed ID: 18664872
    [No Abstract]   [Full Text] [Related]  

  • 7. The emergence of CD20-/CD19- tumor cells after rituximab therapy for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder complicated with hemophagocytic lymphohistiocytosis.
    Yamamoto N; Nishimura N; Takeuchi M; Ito T; Yokozaki H; Hirase S; Kubokawa I; Mori T; Yanai T; Hayakawa A; Takeshima Y; Nishio H; Matsuo M; Imadome K; Iijima K
    Eur J Pediatr; 2014 Dec; 173(12):1615-8. PubMed ID: 24169729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis.
    Balamuth NJ; Nichols KE; Paessler M; Teachey DT
    J Pediatr Hematol Oncol; 2007 Aug; 29(8):569-73. PubMed ID: 17762500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary EBV infection resulting in lymphoproliferative disease in a teenager with Crohn disease.
    Gidrewicz D; Lehman D; Rabizadeh S; Majlessipour F; Dubinsky M
    J Pediatr Gastroenterol Nutr; 2011 Jan; 52(1):103-5. PubMed ID: 20890216
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab-containing immuno-chemotherapy regimens are effective for the elimination of EBV for EBV-HLH with only and mainly B lymphocytes of EBV infection.
    Meng GQ; Wang JS; Wang YN; Wei N; Wang Z
    Int Immunopharmacol; 2021 Jul; 96():107606. PubMed ID: 33826999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining an antiviral with rituximab in EBV-related haemophagocytic lymphohistiocytosis led to rapid viral clearance; and a comprehensive review.
    Stefanou C; Tzortzi C; Georgiou F; Timiliotou C
    BMJ Case Rep; 2016 Dec; 2016():. PubMed ID: 27941111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe CMV-related pneumonia complicated by the hemophagocytic lymphohistiocytic (HLH) syndrome in quiescent Crohn's colitis: harmful cure?
    Presti MA; Costantino G; Della Torre A; Belvedere A; Cascio A; Fries W
    Inflamm Bowel Dis; 2011 Nov; 17(11):E145-6. PubMed ID: 21826767
    [No Abstract]   [Full Text] [Related]  

  • 13. A nearly fatal primary Epstein-Barr virus infection associated with low NK-cell counts in a patient receiving azathioprine: a case report and review of literature.
    Honkila M; Niinimäki R; Taskinen M; Kuismin O; Kettunen K; Saarela J; Turunen S; Renko M; Tapiainen T
    BMC Infect Dis; 2019 May; 19(1):404. PubMed ID: 31077135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus-associated hemophagocytic syndrome in a patient with Crohn's disease receiving azathioprine.
    Hernández-Camba A; Lakhwani S; Ramos L; Raya JM; Quintero E
    J Gastrointestin Liver Dis; 2013 Dec; 22(4):471-2. PubMed ID: 24369333
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytomegalovirus associated hemophagocytic lymphohistiocytosis in patients suffering from Crohn's disease treated by azathioprine: a series of four cases.
    N'Guyen Y; Baumard S; Salmon JH; Lemoine L; Lévêque N; Servettaz A; Jaussaud R; Strady C; Andreoletti L
    Inflamm Bowel Dis; 2011 Sep; 17(9):E116-8. PubMed ID: 21710533
    [No Abstract]   [Full Text] [Related]  

  • 16. Epstein-Barr virus and parvovirus B19 coinfection in a Crohn's disease patient under azathioprine.
    Moreira T; Lago P; Salgado M; Pimentel R
    Inflamm Bowel Dis; 2010 Jun; 16(6):905-6. PubMed ID: 19760779
    [No Abstract]   [Full Text] [Related]  

  • 17. Seroprevalence of Epstein-Barr Virus, Cytomegalovirus, and Polyomaviruses in Children with Inflammatory Bowel Disease.
    Hradsky O; Copova I; Zarubova K; Durilova M; Nevoral J; Maminak M; Hubacek P; Bronsky J
    Dig Dis Sci; 2015 Nov; 60(11):3399-407. PubMed ID: 26091801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Crohn's disease, thiopurines, and primary epstein-barr virus infection with hemophagocytic lymphohistiocytosis.
    Biank VF; Sheth MK; Talano J; Margolis D; Simpson P; Kugathasan S; Stephens M
    J Pediatr; 2011 Nov; 159(5):808-12. PubMed ID: 21722918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus infection is an important cause of hemophagocytic lymphohistiocytosis during chemotherapy for lymphoma.
    Jin Z; Wang Y; Wei N; Wang Z
    Infect Dis Now; 2021 May; 51(3):310-311. PubMed ID: 33934811
    [No Abstract]   [Full Text] [Related]  

  • 20. PD-1 blockade with nivolumab-controlled Epstein-Barr virus infection and associated haemophagocytic lymphohistiocytosis: a case report.
    Dong LH; Liu J; Zu P; Gao X; Du JW; Wang YS; Li YF
    Clin Microbiol Infect; 2019 Nov; 25(11):1438-1440. PubMed ID: 31229591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.